Document is current
Any future updates will be listed below
-
Authors
Sagara, Yasuaki https://orcid.org/0000-0001-5705-1739
Takada, Masahiro
Ohi, Yasuyo
Ohtani, Shoichiro
Kurozumi, Sasagu
Inoue, Kenichi
Kosaka, Yoshimasa
Hattori, Masaya
Yamashita, Toshinari
Takao, Shintaro
Sato, Nobuaki
Iwata, Hiroji
Kurosumi, Masafumi
Toi, Masakazu
- License Information
-
More Information
Article History
Received: 27 March 2018
Accepted: 29 June 2018
First Online: 3 July 2018
Compliance with ethical standards
:
: We declare following potential conflict of interests regarding this study: Remuneration from Chugai (Y. Sagara, M. Takada, S. Ohtani, M. Hattori, K. Inoue, T. Yamashita, N. Sato, H. Iwata, M. Toi), Novartis (T. Yamashita, M. Toi), Eisai (S. Ohtani, T. Yamashita, N. Sato), Takeda (M. Toi), MSD (M. Toi), AstraZeneca (N. Sato, M. Toi), Genomic Health (M. Toi), Taiho (N. Sato, M. Toi). Consultant/advisory role of Daiichi-Sankyo (M. Toi), Pfizer (N. Sato), Kyowa-Hakko-Kirin (M. Toi). Research Funding from Chugai (M. Toi), Taiho (N. Sato, M. Toi), C&C Research Laboratories (M. Toi). Other authors declare no potential conflict of interest.
